Improving the bioavailability of peptide-based therapeutics for the treatment of Multiple Sclerosis

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/536578

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Many diseases are controlled at the molecular level by proteins and their interactions with other proteins. Harmonin is a key protein in Usher syndrome, the most common form of deaf-blindness in humans, and harmonin has similarities to some proteins involved in Alzheimer’s disease. We seek to understand how harmonin works. The findings of this study may lead to new treatments for deaf-blindness and Alzheimer’s disease.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2013

Funding Scheme: Early Career Fellowships

Funding Amount: $341,123.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Biochemistry And Cell Biology Not Elsewhere Classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Biochemistry and protein structure | Molecular mechanisms of deafness and blindness | NMR spectroscopy | X-ray crystallography | computer simulation

Related Links